I am a terrible coder. I think I am a pretty good doctor, but when it comes to coding, the process of figuring out which billing code to pick to assign to a bill for an office visit, I am hopeless. No matter how many times I have had the rules explained to me, or […]
Instead of waiting for congressional action, federal regulators are looking at a series of actions to spur competition and drive down the cost of medicines.
Instead of waiting for congressional action, federal regulators are looking at a series of actions to spur competition and drive down the cost of medicines.
The moves could lead to a dramatic decrease in hospitals and doctors participating in the program, industry officials said.
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Anna Edney of Bloomberg News, Margot Sanger-Katz of The New York Times and Kimberly Leonard of the Washington Examiner talk about the latest Trump administration efforts to address high drug prices, what’s next for short-term health insurance plans and insider trading charges against a New York GOP congressman.
Inspector general identifies possible problems in nearly 23 percent of pharmacies that bill Medicare for blended creams, gels and lotions.
Inspector general identifies possible problems in nearly 23 percent of pharmacies that bill Medicare for blended creams, gels and lotions.
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Anna Edney of Bloomberg News, Alice Ollstein of Talking Points Memo and Rebecca Adams of CQ Roll Call talk about health care’s emergence as a possible voting issue in the coming midterm elections. Plus, Rovner interviews KHN’s Emmarie Huetteman about July’s “Bill of the Month”: a transgender woman’s “bait-and-switch” $92,000 surgical bill.
The Trump administration says its plan to overhaul the way Medicare pays doctors will save physicians time and paperwork. But critics worry the changes will hurt patients’ care and doctors’ income.
A new government watchdog report outlines vulnerabilities in Medicare’s $17 billion hospice program, pointing to inadequate services, inappropriate billing and outright fraud.
